Neurocrine Biosciences, Inc. (NBIX) vs Repligen Corporation (RGEN)
Detailed comparison between Neurocrine Biosciences, Inc., Repligen Corporation.Total Return (%)
Neurocrine Biosciences, Inc. (NBIX)Repligen Corporation (RGEN)
Which stock do you think will perform better?
Neurocrine Biosciences, Inc.
NBIX
Repligen Corporation
RGEN
| Metric | Neurocrine Biosciences, Inc. (NBIX) | Repligen Corporation (RGEN) |
|---|---|---|
| Current Price | $141.83 | $162.51 |
| Change | 2.85 (2.05%) | 8.15 (5.28%) |
| Market Cap | $14.14B | $9.15B |
| Trailing P/E | 33.93 | 8125.50 |
| Forward P/E | 22.84 | 91.30 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $157.67 | $182.52 |
| 52-Week Low | $84.23 | $102.97 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $4.18 | $0.02 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NBIX | 0.25% | -3.36% | 12.88% | 51.50% | 158.63% | 158.63% |
| RGEN | 3.24% | -2.60% | 13.98% | -12.57% | 486.47% | 486.47% |